311 related articles for article (PubMed ID: 3552350)
1. Myelodysplastic syndromes: natural history and features of prognostic importance.
Mufti GJ; Galton DA
Clin Haematol; 1986 Nov; 15(4):953-71. PubMed ID: 3552350
[No Abstract] [Full Text] [Related]
2. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
Galton DA
Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
[No Abstract] [Full Text] [Related]
3. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
[TBL] [Abstract][Full Text] [Related]
4. [The myelodysplastic syndrome based on our cases].
Bozóky G; Farkas L; Serényi P; Biliczki F
Orv Hetil; 1986 Aug; 127(33):1993-8. PubMed ID: 3466134
[No Abstract] [Full Text] [Related]
5. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
6. Factors influencing nonleukemic death in refractory anemia, refractory anemia with ring sideroblasts, and refractory anemia with excess of blasts.
Oguma S; Yoshida Y; Uchino H; Maekawa T
Cancer Res; 1987 Jul; 47(13):3599-602. PubMed ID: 3581090
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes.
Takagi S; Tanaka O; Origasa H; Miura Y
J Clin Oncol; 1999 Jan; 17(1):277-83. PubMed ID: 10458243
[TBL] [Abstract][Full Text] [Related]
8. Chromosome studies in human hematologic diseases: II. Myelodysplastic syndromes.
Larripa I; Labal de Vinuesa M; Bengiò R; Slavutsky I
Haematologica; 1987; 72(5):399-403. PubMed ID: 3121461
[No Abstract] [Full Text] [Related]
9. Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia.
Estey EH; Keating MJ; Dixon DO; Trujillo JM; McCredie KB; Freireich EJ
Hematol Pathol; 1987; 1(4):203-8. PubMed ID: 3504436
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
Omine M; Yamauchi H
Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
[TBL] [Abstract][Full Text] [Related]
12. Chromosome abnormalities in the myelodysplastic syndromes.
Heim S; Mitelman F
Clin Haematol; 1986 Nov; 15(4):1003-21. PubMed ID: 3552345
[No Abstract] [Full Text] [Related]
13. Oncogene mutation and prognosis in the myelodysplastic syndromes.
Padua RA; West RR
Br J Haematol; 2000 Dec; 111(3):873-4. PubMed ID: 11122149
[TBL] [Abstract][Full Text] [Related]
14. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in refractory anemias.
Oguma S; Yoshida Y; Uchino H; Maekawa T
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1412-8. PubMed ID: 3247816
[No Abstract] [Full Text] [Related]
16. [Myelodysplastic syndromes].
Sainty D; Horschowski N; Fossat C; Sampol J
Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
[No Abstract] [Full Text] [Related]
17. Refractory anemia with ringed sideroblasts (primary acquired sideroblastic anemia).
Tomonaga M
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1419-27. PubMed ID: 2854694
[No Abstract] [Full Text] [Related]
18. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
[TBL] [Abstract][Full Text] [Related]
19. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
20. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
Di Giovanni S; Giallonardo P; Costa MP; Carducci P
Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
[No Abstract] [Full Text] [Related]
[Next] [New Search]
